00557 TIANYUAN HEALTH
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 3.55X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | 18.4% | Net Margin | N/A |
Total Debt/Equity | 21.0% | Return on Equity | N/A |
Price/Book | 1.62X | Return on Assets | N/A |
(HKD 0.790) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -34.24 | -15.48 | -29.04 | -16.85 | -65.10 |
---|---|---|---|---|---|
Net Profit Growth (%) | -121.1 | +46.7 | -72.3 | +74.1 | +54.6 |
Earnings Per Share (HKD) | -0.086 | -0.039 | -0.073 | -0.042 | -0.163 |
Earnings Per Share Growth (%) | -121.1 | +46.7 | -72.5 | +74.1 | +54.6 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | N/A | N/A | N/A | N/A | N/A |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | 0.488 | 0.577 | 0.562 | 0.642 | 0.671 |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
(HKDMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
Cover Period (mths) | 12 | 12 | NA | 12 |
---|---|---|---|---|
Turnover | 26.845 | 45.23 | -40.6 | 54.216 |
Operating Result | -38.342 | -28.413 | +34.9 | -40.57 |
Associates | -0.014 | -0.365 | -96.2 | 0.242 |
Profit Before Taxation | -38.429 | -28.778 | +33.5 | -40.349 |
Taxation | 0.177 | -1.821 | -109.7 | 0 |
Profit /( Loss) After Taxation | -38.606 | -26.957 | +43.2 | -40.349 |
Minority Interests | -4.368 | -11.473 | -61.9 | -11.313 |
Net Profit | -34.238 | -15.484 | +121.1 | -29.036 |
Earnings Per Share () | -0.0858 | -0.0388 | +121.1 | -0.0728 |
Announcement Date | 2025-03-28 | 2024-03-26 | NA | 2023-03-30 |
* Annualised
Last Update Time: 2025-07-22 21:40:25